Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Medinotec (MDNC) Common Equity (2022 - 2025)

Historic Common Equity for Medinotec (MDNC) over the last 4 years, with Q4 2025 value amounting to $5.5 million.

  • Medinotec's Common Equity rose 9464.13% to $5.5 million in Q4 2025 from the same period last year, while for Nov 2025 it was $5.5 million, marking a year-over-year increase of 9464.13%. This contributed to the annual value of $4.3 million for FY2025, which is 9706.93% up from last year.
  • According to the latest figures from Q4 2025, Medinotec's Common Equity is $5.5 million, which was up 9464.13% from $4.8 million recorded in Q3 2025.
  • Over the past 5 years, Medinotec's Common Equity peaked at $5.5 million during Q4 2025, and registered a low of -$469985.0 during Q1 2022.
  • Moreover, its 4-year median value for Common Equity was $2.6 million (2022), whereas its average is $2.9 million.
  • Within the past 5 years, the most significant YoY rise in Medinotec's Common Equity was 64385.88% (2023), while the steepest drop was 3704.49% (2023).
  • Medinotec's Common Equity (Quarter) stood at $3.3 million in 2022, then plummeted by 37.04% to $2.1 million in 2023, then soared by 36.17% to $2.8 million in 2024, then soared by 94.64% to $5.5 million in 2025.
  • Its Common Equity was $5.5 million in Q4 2025, compared to $4.8 million in Q3 2025 and $4.4 million in Q2 2025.